Relationship between ex vivo anti‐proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222
- 1 November 1988
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 70 (3) , 335-340
- https://doi.org/10.1111/j.1365-2141.1988.00335.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparationThrombosis Research, 1984
- Anticoagulant effects of two types of low molecular weight heparin administered subcutaneouslyThrombosis Research, 1983
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fractionThrombosis Research, 1982
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Anticoagulant activities of four unfractionated and fractionated heparinsThrombosis Research, 1978
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974